| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
| Suitable for: | Elderly, Children, Adult |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product name | Lapatinib |
| Cas number | 231277-92-2 |
| Appearance | White powder |
| MF | C29H26ClFN4O4S |
| MW | 581.057543 |
Lapatinib ditosylate is approved to be used with other drugs to treat: Breast cancer that is advanced or has metastasized (spread to other parts of the body).
It is used with:Capecitabine in women with HER2 positive (HER2+) breast cancer whose disease has not gotten better with other chemotherapy, in postmenopausal women with HER2+ and hormone receptor positive breast cancer who need hormone therapy.Lapatinib ditosylate is also being studied in the treatment of other types of cancer.
In the experiment of Chinese hamster, no carcinogenic effect was found, and no genetic toxicity was found. There was no effect on mating ability and fertility of rats under high dose. There are 1 cases reported in pregnant women in March before taking lapatinib, full-term pregnancy after the birth of healthy children .
Lapatinib in Indonesia and capecitabine combination in the treatment of breast cancer, the effect is better, and of anthracene ring antibiotics, taxanes and trastuzumab resistant patients effective, mild side effects, for advanced or metastatic breast cancer patients and a drug treatment.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}